The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
The Metropolitan Police is to pay over £400,000 in compensation to a woman who had a child with an undercover officer.
Local councils want ban on term time holidays scrapped because it is too rigid.
It will be a wet start tomorrow for many but things are looking up for the afternoon.